LOVELACE WOMENS HOSPITAL
1. Target Overview & Investment Thesis
LOVELACE WOMENS HOSPITAL is a 162-bed suburban community hospital in BERNALILLO, NM with $198.8M in net patient revenue and a 7.9% operating margin. The hospital serves a payer mix of 8.9% Medicare, 2.6% Medicaid, and 88.5% commercial.
Thesis: Turnaround. Our ML models identify $14.6M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 7.9% to 15.2% (+736bps).
| Net Revenue HCRIS | $198.8M |
| Current EBITDA COMPUTED | $15.6M |
| Operating Margin COMPUTED | 7.9% |
| Occupancy HCRIS | 51.4% |
| Revenue / Bed COMPUTED | $1.2M |
| Net-to-Gross HCRIS | 15.8% |
| Distress Probability ML | 45.2% |
2. Market Context & Competitive Position
NM has 55 Medicare-certified hospitals with a median operating margin of -2.7%. The target's margin of 7.9% places it above the state median. Among 11 size-comparable peers (81-324 beds), the median margin is 8.7%. The target's below-peer margin suggests operational improvement opportunity.
3. RCM Performance Analysis — Comparable Hospitals
Comps selected by bed count (81-324), prioritizing same-state peers. 11 hospitals in the comp set.
| Hospital | State | Beds | Revenue | Margin |
|---|---|---|---|---|
| LOVELACE WOMENS HOSPITAL (Target) | NM | 162 | $198.8M | 7.9% |
| ST. VINCENT HOSPITAL | NM | 189 | $554.3M | -0.6% |
| SAN JUAN REGIONAL MEDICAL CENT | NM | 191 | $346.9M | -4.6% |
| LOVELACE MEDICAL CENTER- DOWNT | NM | 286 | $338.4M | -11.2% |
| MEMORIAL MEDICAL CENTER | NM | 199 | $322.7M | 8.7% |
| MOUNTAIN VIEW REG MED CTR | NM | 166 | $262.2M | 25.7% |
| EASTERN NEW MEXICO MEDICAL CEN | NM | 120 | $117.8M | 54.3% |
| PLAINS REGIONAL MEDICAL CTR - | NM | 100 | $113.3M | -1.4% |
| LOVELACE WESTSIDE HOSPITAL | NM | 92 | $65.1M | 8.9% |
4. Predicted Improvement Opportunities
Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $14.6M (736bps margin improvement).
| Lever | Current | Target | EBITDA Impact | Margin | Ramp |
|---|---|---|---|---|---|
| Net Collection Rate | 93.5% | 97.0% | $4.2M | +210bp | 18mo |
| Cost to Collect | 4.5% | 2.5% | $4.0M | +200bp | 12mo |
| Denial Rate Reduction | 12.0% | 6.5% | $3.9M | +198bp | 12mo |
| A/R Days Reduction | 5200.0% | 3800.0% | $2.4M | +122bp | 9mo |
| Clean Claim Rate | 88.0% | 96.0% | $127K | +6bp | 6mo |
5. EBITDA Bridge
| Current EBITDA | $15.6M |
| + RCM Uplift | +$14.6M |
| Pro Forma EBITDA | $30.2M |
| Current Margin | 7.9% |
| Pro Forma Margin | 15.2% |
| WC Released (1x) | $7.6M |
6. Returns Analysis — Scenario Matrix
5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.
| Scenario | Entry | Exit | Equity In | Equity Out | MOIC | IRR |
|---|---|---|---|---|---|---|
| Base Case | 10.0x | 10.0x | $24.0M | $249.3M | 10.38x | 59.7% |
| Base (11x exit) | 10.0x | 11.0x | $24.0M | $282.0M | 11.74x | 63.7% |
| Bull Case | 9.0x | 11.0x | $21.6M | $338.1M | 15.64x | 73.3% |
| Bull (12x exit) | 9.0x | 12.0x | $21.6M | $375.2M | 17.36x | 77.0% |
| Bear Case | 11.0x | 10.0x | $26.4M | $168.3M | 6.37x | 44.8% |
| Bear (11x exit) | 11.0x | 11.0x | $26.4M | $193.7M | 7.33x | 49.0% |
7. Key Risks & Mitigants
| Severity | Risk Factor | Mitigant |
|---|---|---|
| Low | Low net-to-gross ratio | Large contractual allowances suggest pricing discipline issues. Mitigant: payer renegotiation is an additional upside lever |
8. Data Sources & Methodology Appendix
Data Sources
- CMS HCRIS Cost Reports (Medicare-certified hospitals)
- CMS Medicare Utilization (DRG-level volumes)
- CMS Chronic Conditions (county-level disease prevalence)
- HCRIS multi-year trend data (financial time series)
Comparable Selection
- 11 hospitals with 81-324 beds
- Same-state prioritization (n=12)
- Comp margins: P25=-2.7% / P50=8.7% / P75=14.5%
Bridge Methodology
- Targets: P75 of comparable peers (60% gap closure)
- Denial: avoidable share = 35% of delta × NPR
- AR: bad debt coefficient = $0.65 per day per $1K NPR
- NCR: 60% coefficient on collection rate improvement
- CDI: 0.75% of Medicare revenue per 0.01 CMI point
Returns Assumptions
- Leverage: 5.5x entry (84.6% debt / 15.4% equity)
- Organic growth: 3% annual EBITDA growth
- Debt paydown: 10% of principal per year
- Hold period: 5 years
Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.